ImmunoPrecise Antibodies (IPA) has notable insider buying

ImmunoPrecise Antibodies (V:IPA)

Gianpaolo Fabrisio Andreola, a Director, acquired 50,000 Common Shares on a direct ownership basis at a price of $1.250 through an exercise of warrants on September 3rd, 2020. This represents a $62,500 investment into the company's shares and an account share holdings change of 2.4%.

Immunoprecise Antibodies Ltd, formerly Tanqueray Exploration Ltd, is a Canada-based supplier of custom hybridoma development services. The Company's geographical segments include United States of America and Canada. It offers products, such as antibodies and hybridoma licensing. It offers various services, such as ImmunoProtect, Monoclonal Development, Polyclonal Development, Antibody Protection, Peptide Production and Cryopreservation Services. Its antibody products include IPA006A, IPA006B and IPA006F, which it offers to the research and industrial community. Its hybridoma licensing products include Anti-Human P38a (MAPKinase) Monoclonal Antibody Hybridoma Cell Line and Anti-Acetylated Lysine Monoclonal Antibody Hybridoma Cell Line. It offers cryopreservation storage service for the secure storage of users' valuable biological materials, including hybridoma clones, plasmid constructs and cell lines. It also offers both peptide synthesis and protein carrier conjugation services.